These contrasting findings highlight the complexity of the role of apelin in depression and underscore the need for further research to clarify how plasma and serum apelin levels influence depressive states differently, and to determine which is a more accurate biomarker for mood disorders. This evidence concerns the gene APLN and major depressive disorder.